Skip to Main Content


Skip Nav Destination
Issue Cover
Current Issue
Volume 8,
Issue 8,
April 23 2024

Featured Content

Tyrosine kinase inhibitor resistance in de novo BCR::ABL1–positive BCP-ALL beyond kinase domain mutations

Incidence and risk factors of pain crisis after hematopoietic cell transplantation for sickle cell disease

A molecular circuit linking the BCR to the NAD biosynthetic enzyme NAMPT is an actionable target in Richter syndrome

Sinonasal DLBCL: molecular profiling identifies subtypes with distinctive prognosis and targetable genetic features

Monocytes in leukapheresis products affect the outcome of CD19–targeted CAR T-cell therapy in patients with lymphoma

Guadecitabine vs TC in relapsed/refractory AML after intensive chemotherapy: randomized phase 3 ASTRAL-2 trial

Close Modal

or Create an Account

Close Modal
Close Modal